Incidence and Temporal Changes of Transfusion and Coagulation Management in Cardiac Surgery: Insights From the

Caroline M Schaap1, Jimmy Schenk2, Susanne Eberl3

  • 1Department of Intensive Care Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.

Insights

Perioperative transfusion rates for red blood cells (RBCs) and other blood products in Dutch cardiac surgery have risen significantly between 2016 and 2023. This increase shows considerable variation among hospitals, independent of patient factors.

Area of Science:

  • Cardiovascular Surgery
  • Transfusion Medicine
  • Health Services Research

Background:

  • Perioperative transfusion is common in cardiac surgery.
  • Understanding transfusion practices, variability, and trends is crucial for patient outcomes.
  • The Netherlands Heart Registration (NHR) provides a national dataset for such analyses.

Purpose of the Study:

  • To describe perioperative transfusion rates in Dutch cardiac surgery.
  • To investigate hospital variability and temporal trends in transfusion practices.
  • To explore the association between red blood cell (RBC) transfusion and patient/procedural characteristics.

Main Methods:

  • Nationwide retrospective cohort study utilizing NHR data.
  • Inclusion of adult patients undergoing cardiac surgery across all 16 Dutch centers (2016-2023).
  • Analysis of transfusion rates for RBCs, plasma, platelets, and other hemostatic agents, alongside interhospital variability and temporal trends.

Main Results:

  • Overall transfusion rates: RBCs (30.6%), plasma (11.0%), platelets (20.3%).
  • Significant intercenter variability in transfusion rates was observed.
  • Annual transfusion rates increased for most products, including RBCs (OR 1.02), with a similar trend persisting after adjusting for patient/procedural factors (aOR 1.03).

Conclusions:

  • Perioperative transfusion rates in Dutch cardiac surgery have increased and exhibit substantial intercenter variability.
  • The rise in RBC transfusions was not fully explained by changes in measured patient or procedural characteristics.
  • Continuous monitoring of transfusion practices is essential to understand temporal trends and variations in clinical practice.
Abstract

Related Concept Videos